ロード中...
Estimating the effect size of the 15Q11.2 BP1–BP2 deletion and its contribution to neurodevelopmental symptoms: recommendations for practice
BACKGROUND: The 15q11.2 deletion is frequently identified in the neurodevelopmental clinic. Case–control studies have associated the 15q11.2 deletion with neurodevelopmental disorders, and clinical case series have attempted to delineate a microdeletion syndrome with considerable phenotypic variabil...
保存先:
| 出版年: | J Med Genet |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6817694/ https://ncbi.nlm.nih.gov/pubmed/31451536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmedgenet-2018-105879 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|